Connect Biopharma Presents Data Supporting Rademikibart at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress
– Rademikibart significantly improved lung function and asthma control in patients with…
Connect Biopharma to Present at Two Upcoming Investor Conferences in June
SAN DIEGO, May 28, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited…
EAACI Congress 2025 – Breaking Boundaries in Allergy, Asthma, and Clinical Immunology: Integrating Planetary Health for a Sustainable Future
ZURICH, March 18, 2025 (GLOBE NEWSWIRE) -- The European Academy of Allergy…
Jasper Therapeutics Presents Clinical and Preclinical Briquilimab Data at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting
REDWOOD CITY, Calif., March 01, 2025 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc.…
Revolo to Present at the 2025 AAAAI / WAO Joint Congress
February 10, 2025 12:00 ET | Source: Revolo Biotherapeutics GAITHERSBURG, Md. and…
Albus Health Device Detects Early Warning Signs of Child Asthma Attacks Up To Five Days Before Onset
November 29, 2024 04:00 ET | Source: Albus Health Albus Health Device…